Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | MYOC | Q99972 | 1/20 | 0.46 |
| ▸ | BCL9 | O00512 | 1/20 | 0.45 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.45 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL357343 | 0.83 | HSPB1 (0.52) | CA1CA2CES1CES2HSPB1 | |
| SCHEMBL15588700 | 0.80 | HSPB1 (0.48) | CA1CA2CES1CES2HSPB1 | |
| SCHEMBL30777840 | 0.80 | HSPB1 (0.48) | CA1CA2CES1CES2HSPB1 | |
| SCHEMBL15849787 | 0.80 | MEN1 (0.30) | KMT2AMEN1 | |
| SCHEMBL15909498 | 0.78 | TSHR (0.53) | CES1CES2TDP1ACHE | |
| SCHEMBL1962543 | 0.78 | TSHR (0.53) | CES1CES2TDP1ACHE | |
| SCHEMBL5409494 | 0.77 | ALDH1A1 (0.54) | CA1CA2CES1CES2HSPB1 | |
| SCHEMBL9466346 | 0.74 | HSPB1 (0.61) | CA1CA2CES1CES2HSPB1 | |
| 4,4'-Oxybis(Nitrobenzene) SCHEMBL134332 | 0.73 | HSPB1 (0.79) | CA1CA2CES1CES2HSPB1 | |
| SCHEMBL11689190 | 0.73 | HSPB1 (0.79) | CA1CA2CES1CES2HSPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326723-A1 | Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly | UNIV NORTHWESTERN (US) | 2025-10-23 | — | — | US | claimed |
| WO-2024025604-A9 | DEVELOPMENT OF AN ENZYME-INHIBITOR REACTION USING CELLULAR RETINOIC ACID BINDING PROTEIN II FOR ONE-POT MEGAMOLECULE ASSEMBLY | NORTHWESTERN UNIVERSITY (US) | 2024-05-02 | — | — | WO | claimed |
| WO-2024025604-A2 | DEVELOPMENT OF AN ENZYME-INHIBITOR REACTION USING CELLULAR RETINOIC ACID BINDING PROTEIN II FOR ONE-POT MEGAMOLECULE ASSEMBLY | NORTHWESTERN UNIVERSITY (US) | 2024-02-01 | — | — | WO | claimed |
| CN-110612119-A | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents | 西雅图儿童医院（DBA西雅图儿童研究所） | 2019-12-24 | — | — | CN | claimed |
| US-20190161556-A1 | Fusion Protein Construct | NORTHWESTERN UNIVERSITY | 2019-05-30 | — | — | US | claimed |
| CN-109661407-A | Fusion protein constructs | 西北大学 | 2019-04-19 | — | — | CN | claimed |
| EP-2311939-A1 | Polypeptide immobilization | The University of Chicago (US) | 2011-04-20 | — | — | EP | claimed |
| US-7888055-B2 | Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity | THE UNIVERSITY OF CHICAGO (US) | 2011-02-15 | — | — | US | claimed |
| WO-2026101423-A1 | PHOTOSWITCHABLE CHEMICAL INDUCED DIMERIZATION SYSTEMS FOR CONTROL OF CELLULAR ACTIVITIES WITH LIGHT | WU YAOWEN (SE) | 2026-05-15 | — | — | WO | disclosed |
| US-20260063641-A1 | COMPOSITIONS AND METHODS FOR LABELING AND DETECTING BINDING PARTNERS | UNIV UTAH RES FOUND (US) | 2026-03-05 | — | — | US | disclosed |
| US-20250326723-A1 | Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly | UNIV NORTHWESTERN (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4565594-A2 | COMPOSITIONS AND METHODS FOR LABELING AND DETECTING BINDING PARTNERS | University of Utah Research Foundation (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250059301-A1 | Fusion Protein Construct | NORTHWESTERN UNIVERSITY | 2025-02-20 | — | — | US | disclosed |
| CN-119438107-A | Visual detection method for organochlorine pesticide based on metal-organic framework immobilized enzyme composite material | 吉林大学 | 2025-02-14 | — | — | CN | disclosed |
| WO-1997040141-A2 | ISOLATION OF ENZYMES | MEDICAL RESEARCH COUNCIL (GB) | 1997-10-30 | — | — | WO | disclosed |
| EP-0362304-B1 | CHEMICAL SENSORS EMPLOYING CATALYTIC ANTIBODIES | IGEN INC (US) | 1997-03-05 | — | — | EP | disclosed |
| WO-1993012144-A1 | ANTIBODY-MEDIATED REDUCTION OF α-KETOAMIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1993-06-24 | — | — | WO | disclosed |
| EP-0362304-A4 | CHEMICAL SENSORS EMPLOYING CATALYTIC ANTIBODIES | — | 1991-04-10 | — | — | EP | disclosed |
| EP-0362304-A1 | CHEMICAL SENSORS EMPLOYING CATALYTIC ANTIBODIES. | IGEN INC (US) | 1990-04-11 | — | — | EP | disclosed |
| WO-1989005977-A1 | CHEMICAL SENSORS EMPLOYING CATALYTIC ANTIBODIES | IGEN, INC. (US) | 1989-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260063641-A1 | COMPOSITIONS AND METHODS FOR LABELING AND DETECTING BINDING PARTNERS | ATIC, JMJD7, UCHL1 | CA1 4569/4885CA2 4467/4885CES1 399/4885 |
| US-20250059301-A1 | Fusion Protein Construct | RPS27A, CD2BP2, JMJD7 | CA1 1971/4885CA2 2987/4885CES1 926/4885 |
| US-20190161556-A1 | Fusion Protein Construct | RPS27A, CD2BP2, JMJD7 | CA1 1971/4885CA2 2987/4885CES1 926/4885 |
| US-20250326723-A1 | Development of an Enzyme-Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One-Pot Megamolecule Assembly | CRABP2, RARB, RARA | CA1 1293/4885CA2 620/4885CES1 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.